Skip to main content

Cardiovascular Biomarkers

Pathophysiology and Disease Management

  • Book
  • © 2006

Overview

Part of the book series: Contemporary Cardiology (CONCARD)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (34 chapters)

  1. Biomarkers of Necrosis

  2. Biomarkers of Ischemia

  3. Biomarkers of Inflammation

Keywords

About this book

In the four pages committed to a discussion of myocardial infarction in the first edition of Harrison’s Principles of Internal Medicine, published in 1950, there was no mention of use of the laboratory for management of patients. Thirty years later, when the first edition of Braunwald’s Heart Disease, A Textbook of Cardiovascular Medicine was published, 2 out of the 1943 pages in the text contained a discussion of the laboratory examinations in acute myocardial infarction. Our knowledge base of the multitude of ways that physicians can and should use the clinical chemistry laboratory has expanded dramatically since these classic texts were published. The nomenclature has changed: terms such as “cardiac enzymes” have given way to “cardiac biomarkers. ” The number of assays has multiplied, and the operating characteristics of available assays are impr- ing at a gratifying but dizzying rate. We now use biomarkers to diagnose cardiovascular diseases and also to frame our treatment strategies. Thus, there is a clear need for a scholarly compilation of the state of the art of cardiac biomarkers. Dr. David Morrow has expertly edited an authoritative book that answers this need. The 34 chapters in Cardiovascular Biomarkers: Pathophysiology and Disease Mana- ment were written by a group of individuals who are internationally recognized thought leaders and experts in clinical and laboratory medicine.

Reviews

From the Foreword...

"...readers of this text will find it an invaluable resource regardless of their familiarity with the subject."

From the reviews:

"This book provides a clear presentation of the use of biomarkers in the diagnosis and treatment of cardiovascular diseases. … The author seeks to provide clinicians with an authoritative book on the current state-of-the art in cardiovascular biomarkers. … It is aimed at practicing cardiologists and does an excellent job of defining the development and use of the current set of cardiovascular biomarkers as well as providing insight into the future directions of the field." (Cooper Woods, Doody’s Review Service, March, 2008)

Editors and Affiliations

  • Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston

    David A. Morrow

Bibliographic Information

  • Book Title: Cardiovascular Biomarkers

  • Book Subtitle: Pathophysiology and Disease Management

  • Editors: David A. Morrow

  • Series Title: Contemporary Cardiology

  • DOI: https://doi.org/10.1007/978-1-59745-051-5

  • Publisher: Humana Totowa, NJ

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Humana Press 2006

  • Hardcover ISBN: 978-1-58829-526-2Published: 05 May 2006

  • Softcover ISBN: 978-1-61737-620-7Published: 09 November 2010

  • eBook ISBN: 978-1-59745-051-5Published: 28 April 2010

  • Series ISSN: 2196-8969

  • Series E-ISSN: 2196-8977

  • Edition Number: 1

  • Number of Pages: 640

  • Number of Illustrations: 227 b/w illustrations

  • Topics: Cardiology

Publish with us